Notable reductions in rates of levels one, two, and three hypoglycemia were also observed
While comprehensive comparative data is not yet available, existing evidence provides some initial guidance
UHCs 2026 commercial PA criteria for Wegovy require five elements: BMI of 30 or higher, or BMI 27 to 29.9 with at least one weight-related comorbidity (type 2 diabetes, hypertension, dyslipidemia, OSA, CVD), documentation of a structured weight management program for at least 6 months in the past 24 months, prescriber attestation that lifestyle changes alone have been inadequate, age 18 or older, and concurrent reduced-calorie diet and physical activity
Need comprehensive weight loss support
You know, there's been a bit of Damned if you do, damned if you don't. You're too big
So no matter your needs, you can feel confident youre choosing a gentle, body-friendly path